HEAL DSpace

The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits

Αποθετήριο DSpace/Manakin

Εμφάνιση απλής εγγραφής

dc.contributor.author Andreadou, I en
dc.contributor.author Iliodromitis, EK en
dc.contributor.author Mikros, E en
dc.contributor.author Constantinou, M en
dc.contributor.author Agalias, A en
dc.contributor.author Magiatis, P en
dc.contributor.author Skaltsounis, AL en
dc.contributor.author Kamber, E en
dc.contributor.author Tsantili-Kakoulidou, A en
dc.contributor.author Kremastinos, DT en
dc.date.accessioned 2014-03-01T01:55:43Z
dc.date.available 2014-03-01T01:55:43Z
dc.date.issued 2006 en
dc.identifier.issn 0022-3166 en
dc.identifier.uri https://dspace.lib.ntua.gr/xmlui/handle/123456789/27818
dc.subject.classification Nutrition & Dietetics en
dc.subject.other RADICAL-SCAVENGING PROPERTIES en
dc.subject.other MYOCARDIAL INFARCT SIZE en
dc.subject.other CHOLESTEROL-RICH DIET en
dc.subject.other NITRIC-OXIDE en
dc.subject.other LIPOPROTEIN OXIDATION en
dc.subject.other MAGNETIC-RESONANCE en
dc.subject.other MEDITERRANEAN DIET en
dc.subject.other IN-VITRO en
dc.subject.other OIL en
dc.subject.other HEART en
dc.title The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits en
heal.type journalArticle en
heal.language English en
heal.publicationDate 2006 en
heal.abstract The goal of this study was to evaluate the efficacy of the antioxidant olive constituent, oleuropein, on infarct size, oxidative damage, and the metabolic profile in rabbits subjected to ischemia. Oleuropein, 10 or 20 mg/(kg(.)d), was administered to 8 groups that consumed a normal or hypercholesterolemic diet for 6 wk or only the higher dose for 3 wk. Circulating levels of malondialdehyde, protein carbonyl, nitrite+nitrate, cholesterol, triglycerides, SOD activity, and the metabolic profile were measured using H-1 NMR spectra. In rabbits that consumed the normal diet, the infarct size (percentage of infarct to risk areas) was reduced by the administration of 10 mg oleuropein/(kg(.)d) (16.1 +/- 2.9%) or 20 mg oleuropein/(kg(.)d) for 3 wk (21.7 +/- 2.2%) or for 6 wk (24.3 +/- 1.3%) compared with the control group (48.05 +/- 2.0%, P < 0.05). Only the higher dose of 20 mg/(kg(.)d) reduced the infarct size in hypercholesterolemic rabbits (34.7 +/- 4.4% for 6 wk and 34.8 +/- 6.1 % for 3 wk) compared with the cholesterol-fed control group (52.8 +/- 2.4%, P < 0.05). Oleuropein decreased the plasma lipid peroxidation product and protein carbonyl concentrations compared with the control groups, in which these factors increased relative to baseline due to ischemia and reperfusion. Furthermore, in rabbits administered oleuropein, RBC superoxide dismutase activity did not change during ischemia and reperfusion. This activity was significantly higher than in both control groups in which it was reduced by ischemia and reperfusion compared with baseline. Treatment for 6 wk with both doses of oleuropein reduced total cholesterol and triglyceride concentrations. H-1 NMR spectra revealed a different profile of glycolysis metabolites in the oleuropein-treated groups compared with the controls. Oleuropein, for 3 or 6 wk, reduced the infarct size, conferred strong antioxidant protection and reduced the circulating lipids. This is the first experimental study in vivo that suggests the possibility of using an olive constituent in the treatment, of ischemia. en
heal.publisher AMER SOCIETY NUTRITIONAL SCIENCE en
heal.journalName JOURNAL OF NUTRITION en
dc.identifier.isi ISI:000239366300016 en
dc.identifier.volume 136 en
dc.identifier.issue 8 en
dc.identifier.spage 2213 en
dc.identifier.epage 2219 en


Αρχεία σε αυτό το τεκμήριο

Αρχεία Μέγεθος Μορφότυπο Προβολή

Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στην ακόλουθη συλλογή(ές)

Εμφάνιση απλής εγγραφής